We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$10.5B
AUM Growth
+$349M
Cap. Flow
-$52.6M
Cap. Flow %
-0.5%
Top 10 Hldgs %
33.62%
Holding
112
New
2
Increased
18
Reduced
64
Closed
7

Top Buys

Rank Stock Value
1
ERF
Enerplus Corporation
ERF
+$44.4M
2
MGA icon
Magna International
MGA
+$37.6M
3
BIIB icon
Biogen
BIIB
+$33.6M
4
MRK icon
Merck
MRK
+$31.5M
5
STT icon
State Street
STT
+$27.8M

Sector Composition

Rank Sector Weight
1 Financials 23.61%
2 Energy 18.54%
3 Communication Services 16.5%
4 Technology 9.33%
5 Materials 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPE icon
51
Hewlett Packard
HPE
$76.2B
$65.4M 0.62%
6,154,437
+185,950
+3% +$1.89M
CCJ icon
52
Cameco
CCJ
$39.9B
$54.6M 0.52%
5,005,611
-32,150
-0.6% -$382K
TFC icon
53
Truist Financial
TFC
$62B
$54.6M 0.52%
1,532,970
+532,400
+53% +$18.6M
ERF
54
DELISTED
Enerplus Corporation
ERF
$54.5M 0.52%
8,330,400
+8,260,400
+11,801% +$44.4M
PEP icon
55
PepsiCo
PEP
$185B
$47.8M 0.46%
451,292
-17,867
-4% -$1.84M
GSK icon
56
GSK
GSK
$100B
$47.2M 0.45%
871,754
-11,640
-1% -$613K
FLR icon
57
Fluor
FLR
$7.2B
$46.7M 0.45%
947,698
-12,925
-1% -$672K
MDT icon
58
Medtronic
MDT
$120B
$42.3M 0.4%
487,395
-8,770
-2% -$709K
ERIC icon
59
Ericsson
ERIC
$32.8B
$39.8M 0.38%
5,183,901
-67,875
-1% -$557K
MRO
60
DELISTED
Marathon Oil Corporation
MRO
$36.1M 0.34%
2,407,131
-25,150
-1% -$332K
HPQ icon
61
HP
HPQ
$30.9B
$35M 0.33%
2,792,767
-36,575
-1% -$455K
KMB icon
62
Kimberly-Clark
KMB
$32.4B
$34.9M 0.33%
253,501
-134,875
-35% -$17.7M
ELP
63
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$34.7M 0.33%
9,658,030
-58,750
-0.6% -$182K
BIIB icon
64
Biogen
BIIB
$31.9B
$30.9M 0.29%
+127,665
New +$33.6M
SBS icon
65
Sabesp
SBS
$18.5B
$28.1M 0.27%
16,148,542
-178,674
-1% -$261K
CHL
66
DELISTED
China Mobile Limited
CHL
$25.7M 0.25%
443,725
-950
-0.2% -$53.4K
VWO icon
67
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$25.6M 0.24%
728,000
FSLR icon
68
First Solar
FSLR
$21.9B
$23.4M 0.22%
481,914
-258,205
-35% -$13.8M
LPNT
69
DELISTED
LifePoint Health, Inc.
LPNT
$21.4M 0.2%
327,445
-5,790
-2% -$394K
BB icon
70
BlackBerry
BB
$4.51B
$20.2M 0.19%
3,035,630
+422,140
+16% +$2.95M
PDS
71
Precision Drilling
PDS
$1.13B
$18.8M 0.18%
178,965
-76
-0% -$7.2K
IEMG icon
72
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
$17.8M 0.17%
425,000
SMI
73
DELISTED
Semiconductor Manufacturing Intl
SMI
$14.9M 0.14%
3,676,891
-43,350
-1% -$181K
IIF
74
Morgan Stanley India Investment Fund
IIF
$207M
$14.3M 0.14%
535,150
INFY icon
75
Infosys
INFY
$46.3B
$13.4M 0.13%
1,500,000
-580,000
-28% -$5.43M

Similar funds

Letko, Brosseau & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Letko, Brosseau & Associates held 112 positions worth $10.5B, up 3.4% from $10.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Letko, Brosseau & Associates's Q2 2016 filing shows 2 new, 18 increased, 64 reduced and 7 closed positions. Its largest new stake was Biogen: 127,665 shares worth $30.9M. The largest sale was BAXALTA INC COM STK (DE), an estimated $72M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 24% a quarter earlier, followed by Energy and Communication Services.

  • Letko, Brosseau & Associates's largest Q2 2016 buy was Biogen: 127,665 shares worth $30.9M.
  • Letko, Brosseau & Associates added most to Enerplus Corporation in Q2 2016, an estimated $44.4M increase.
  • Letko, Brosseau & Associates's biggest Q2 2016 reduction was Del Monte Corp, cutting an estimated $52.4M.
  • Letko, Brosseau & Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $72M.
  • Letko, Brosseau & Associates's ten largest holdings make up 34% of its $10.5B portfolio in Q2 2016.
  • Letko, Brosseau & Associates opened 2 new positions and closed 7 in Q2 2016.
  • Letko, Brosseau & Associates's portfolio value rose 3.4% quarter-over-quarter to $10.5B.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2016, filed 4 Aug 2016.